SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-041768
Filing Date
2012-06-05
Accepted
2012-06-05 09:00:39
Documents
5
Period of Report
2012-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-14078_18k.htm 8-K 26792
2 EX-99.1 a12-14078_1ex99d1.htm EX-99.1 11047
3 EX-99.2 a12-14078_1ex99d2.htm EX-99.2 27838
4 GRAPHIC g140781mmi001.jpg GRAPHIC 2191
5 GRAPHIC g140781moi001.jpg GRAPHIC 4058
  Complete submission text file 0001104659-12-041768.txt   75804
Mailing Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121
Business Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121 8589090736
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33291 | Film No.: 12887818
SIC: 2834 Pharmaceutical Preparations